De Groot CJ - Search Results

1

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

De Groot CJ, Montagne L, Barten AD, Sminia P, Van Der Valk P. De Groot CJ, et al. J Neuropathol Exp Neurol. 1999 Feb;58(2):174-87. doi: 10.1097/00005072-199902000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10029100

2

CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis.

Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P, Ravid R, Biber K. Hulshof S, et al. Among authors: de groot cj. J Neuropathol Exp Neurol. 2003 Sep;62(9):899-907. doi: 10.1093/jnen/62.9.899. J Neuropathol Exp Neurol. 2003. PMID: 14533779

3

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

Hulshof S, Montagne L, De Groot CJ, Van Der Valk P. Hulshof S, et al. Among authors: de groot cj. Glia. 2002 Apr 1;38(1):24-35. doi: 10.1002/glia.10050. Glia. 2002. PMID: 11921201

4

Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.

De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. De Groot CJ, et al. J Neuropathol Exp Neurol. 1997 Jan;56(1):10-20. doi: 10.1097/00005072-199701000-00002. J Neuropathol Exp Neurol. 1997. PMID: 8990125

5

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

De Groot CJ, Langeveld CH, Jongenelen CA, Montagne L, Van Der Valk P, Dijkstra CD. De Groot CJ, et al. J Neurosci Res. 1997 Aug 1;49(3):342-54. doi: 10.1002/(sici)1097-4547(19970801)49:3<342::aid-jnr9>3.0.co;2-c. J Neurosci Res. 1997. PMID: 9260745

6

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions.

Van Der Voorn P, Tekstra J, Beelen RH, Tensen CP, Van Der Valk P, De Groot CJ. Van Der Voorn P, et al. Among authors: de groot cj. Am J Pathol. 1999 Jan;154(1):45-51. doi: 10.1016/S0002-9440(10)65249-2. Am J Pathol. 1999. PMID: 9916917 Free PMC article.

7

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

van der Valk P, De Groot CJ. van der Valk P, et al. Among authors: de groot cj. Neuropathol Appl Neurobiol. 2000 Feb;26(1):2-10. doi: 10.1046/j.1365-2990.2000.00217.x. Neuropathol Appl Neurobiol. 2000. PMID: 10736062 Review.

8

Hypothalamic lesions in multiple sclerosis.

Huitinga I, De Groot CJ, Van der Valk P, Kamphorst W, Tilders FJ, Swaab DF. Huitinga I, et al. Among authors: de groot cj. J Neuropathol Exp Neurol. 2001 Dec;60(12):1208-18. doi: 10.1093/jnen/60.12.1208. J Neuropathol Exp Neurol. 2001. PMID: 11764093

9

Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions.

Vos CM, van Haastert ES, de Groot CJ, van der Valk P, de Vries HE. Vos CM, et al. Among authors: de groot cj, de vries he. J Neuroimmunol. 2003 May;138(1-2):106-14. doi: 10.1016/s0165-5728(03)00036-5. J Neuroimmunol. 2003. PMID: 12742660

10

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P. Barkhof F, et al. Among authors: de groot cj. Arch Neurol. 2003 Aug;60(8):1073-81. doi: 10.1001/archneur.60.8.1073. Arch Neurol. 2003. PMID: 12925362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters